- Home
- SGP vs SIBN Comparison
SGP vs SIBN Comparison
Compare SGP & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SGP | SIBN |
|---|---|---|
| Founded | 2019 | 2008 |
| Country | United States | United States |
| Employees | 65 | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 650.9M | 778.8M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | SGP | SIBN |
|---|---|---|
| Price | $25.09 | $18.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $45.00 | $23.88 |
| AVG Volume (30 Days) | 97.2K | ★ 514.0K |
| Earning Date | 05-15-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 41.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $67,301,000.00 |
| Revenue This Year | N/A | $16.95 |
| Revenue Next Year | N/A | $14.93 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 21.53 |
| 52 Week Low | $17.06 | $11.48 |
| 52 Week High | $30.56 | $21.89 |
Technical Indicators
Market Signals| Indicator | SGP | SIBN |
|---|---|---|
| Relative Strength Index (RSI) | 68.69 | 58.62 |
| Support Level | $20.95 | $16.34 |
| Resistance Level | $25.83 | $18.17 |
| Average True Range (ATR) | 1.34 | 0.69 |
| MACD | 0.38 | 0.02 |
| Stochastic Oscillator | 95.56 | 60.84 |
Price Performance
Historical ComparisonAbout SGP SpyGlass Pharma Inc. Common Stock
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.
About SIBN SI-BONE Inc.
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.